Skip to main content

Open Access Tribulus arabicus and Tribulus macropterus are Comparable to Tribulus terrestris: An Antioxidant Assessment

Background: Tribulus terrestris, unlike Tribulus macropterus and Tribulus arabicus, is a well-studied plant species and well known for its medicinal properties. It has been used as a medicine to treat sexual dysfunction and to relieve cardiac pain. It also has other properties such as antihypertensive, anti-microbial, anticancer and antihelmintic. Unfortunately, other Tribulus species such as T. macropterus and T. arabicus (common in the UAE), were not thoroughly investigated for such medicinal properties.

Methods: In this trial, Tribulus terrestris (TT), Tribulus macropterus (TM) and Tribulus arabicus (TA) were tested for their antixodiant properties using DPPH, ABTS, FRAP and β-Carotene assays.

Results: TM and TA showed similar or slightly greater antioxidant properties than TT. Similar DPPH scavenging activities (presented as inhibition percent) were observed for both TM (42.7%) and TA (43.8%), and slightly higher than TT (39.9%) at the maximum concentrations (i.e., 1000 ug/ml). For β-Carotene, TT showed absorbance of 0.28 (control) and 0.35 (at 1000 ug/ml). TM and TA had averages of 0.38 and 0.49 vs 0.190 and 0.23 (control and at 1000 ug/ml, respectively) at 470 nm.

Conclusion: The results reported here showed similar antioxidant potentials of T. macropterus and T. arabicus when compared to T. terrestris, which place these two Tribulus species at similar levels of antioxidant and medicinal properties as T. terrestris. A subsequent investigation on the potentials of T. macropterus and T. arabicus against sexual dysfunctions in rats is planned. The long-term aim would be to treat sexual dysfunctions in humans using T. macropterus and T. arabicus as an alternative to T. terrestris.

Keywords: Plant extracts; Tribulus; UAE; sexual dysfunctions

Document Type: Research Article

Publication date: March 1, 2017

More about this publication?
  • The journal aims to provide updates to researchers about new bioactive compounds with proven activities in various biological screenings and pharmacological models. The journal will contain information about the structures, biological activities and sources of chemical entities discovered or designed by researchers and published in leading journals. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia.

    The journal should prove to be essential reading for pharmacologists, pharmaceutical chemists and medicinal chemists who wish to be kept informed and up-to-date with the latest and most important developments about new bioactive compounds of natural or synthetic origin, including recent patents.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content